Introduction
Machado-Joseph disease (MJD) is an autosomal dominant neurodegenerative disorder of late onset, characterized by cerebellar ataxia, progressive external ophthalmoplegia, and pyramidal signs (Coutinho and Andrade 1978) . The causative mutation is the expansion of a (CAG) n tract in the MJD1 gene, localized on 14q32.1 (Kawaguchi et al. 1994 ): 12-44 repeats in normal genes and 53-87 repeats in mutated genes.
Three intragenic single-nucleotide polymorphisms (SNPs) (Goto et al. 1997) . These intragenic SNPs were used in a worldwide haplotype study to elucidate the ancestral origins of the MJD mutation, which demonstrated haplotype A 669 -C 987 -A 1118 to be shared by the majority of the families studied, suggesting a major founder mutation in MJD Lima et al. 1998) . The intragenic polymorphism C 987 GG/G 987 GG has been implicated in intergenerational instability when present in cis or in trans of the CAG expansion causative of MJD (Igarashi et al. 1996; Maciel et al. 1999) .
To further characterize the MJD1 gene, we studied a Portuguese control population for variability in specific regions of the gene where, by bioinformatics, the existence of novel SNPs was indicated. These SNPs could contribute to the study of the origin of the MJD mutation, the study of the molecular mechanisms for the instability of CAG repeats, and the characterization of the MJD1 gene in the Portuguese population.
Subjects and methods
A Portuguese control population of 76 individuals was studied. Samples were obtained in a random and anonymous manner from all 20 regions of Portugal, including the Azores and Madeira Islands. Genomic DNA was isolated Abstract Machado-Joseph disease (MJD) is an autosomal dominant neurodegenerative disorder of late onset, caused by the expansion of a (CAG) n tract in the MJD1 gene. Using BLAST2 sequences between known cDNA variants transcribed by the MJD1 gene and a clone of human genomic DNA, six possible unknown intragenic singlenucleotide polymorphisms (SNPs), at variable positions in the MJD1 gene, were identified. To confirm this, we studied a Portuguese control population, using polymerase chain reaction amplification and single-strand conformation polymorphism analysis for each potential SNP. For four of the possible polymorphisms there was no variability in our population, but the existence of three novel polymorphisms was confirmed: GTT 527 are located in the 3Јnoncoding region of cDNA variants of the MJD1 gene, MJD2-1 and MJD1-1, respectively. All these novel SNPs are in Hardy-Weinberg equilibrium. These intragenic polymorphisms can be useful for (1) the study of the origin of the MJD mutation(s), (2) the study of recombination events, (3) distinction of chromosomes with alleles of identical (CAG) n size in genetic tests (homoallelism), (4) the study of genetic modifiers in the region flanking the MJD1 gene, and (5) association studies in other diseases.
from peripheral blood in Guthrie cards, normally used for newborn screening of phenylketonuria and congenital hypothyroidism, using Chelex (BioRad) in a final concentration of 0.8%. A multiple alignment (BLAST2 sequences) was made between the known cDNA variants transcribed by the MJD1 gene (Goto et al. 1997 ) and a clone of human genomic DNA from chromosome 14, BAC R-529H20 (accession number AL049723). This comparison suggested the possible existence of six previously unknown intragenic SNPs at variable positions in the MJD1 gene.
To confirm the existence of the six possible intragenic polymorphisms, we amplified a fragment of the MJD1 gene by polymerase chain reaction (PCR), using the specific primers for each SNP, and the same conditions as described for amplification of the CAG repeat (Kawaguchi et al. 1994) , except for the annealing temperature (see Table 1 for primer sequence and annealing temperature). The amplified fragments were analyzed by single-strand conformation polymorphism (SSCP), using a nondenaturing 7% polyacrylamide gel at 4°C, and visualized by autoradiography. Confirmation of the sequence variants was obtained using DNA from individuals with different patterns of migration as obtained by SSCP. DNA sequencing was performed using the Thermo Sequenase Cycle Sequencing kit (Amersham Pharmacia Biotech, Cleveland, USA) following the instructions of the manufacturer. The SNPs C 1178 / A 1178 and A 1294 /G 1294 can also be detected by PCR-restriction fragment length polymorphism: in the first case the restriction enzyme PleI recognizes the allele C but not the A, and in the second case the restriction enzyme NsiI recognizes the allele A but not the G.
The Hardy-Weinberg equilibrium was evaluated with a 2 test. The degree of polymorphism was measured by the polymorphism information content (PIC) value. Given that we tested unrelated individuals in a control sample, it was not possible to determine the phase of chromosomes, and we could not at this point detect if the intragenic polymorphisms are in linkage disequilibrium or not.
Results

Six novel potential intragenic polymorphisms in the MJD1
Discussion
In addition to the three previously known intragenic polymorphisms present in this gene, we identified three novel polymorphisms: GTT 527 /GTC 527 (Val/Val) located in the coding region, and C 1178 /A 1178 and A 1294 /G 1294 located in the 3Јnoncoding region of cDNA variants MJD2-1/MJD1a and MJD1-1/MJD5-1 (Goto et al. 1997; Ichikawa et al. 2001) , respectively.
These intragenic polymorphisms can be useful for (1) the study of the origin of the MJD mutation(s), namely, to broaden the haplotypes in study, since these novel SNPs flank those used in previous studies at both the 5Ј and 3Ј sides; (2) the study of recombination events (proposed by several authors to be involved in the instability of trinucleotide repeats); (3) distinction of chromosomes with alleles of identical (CAG) n size in genetic tests (homoallelism) -in particular, the polymorphism C 1178 /A 1178 has been applied to the improvement of the molecular diagnosis of MJD ; (4) the study of genetic modifiers in the region flanking the MJD1 gene; and (5) association studies in other diseases. 
